Thermo Fisher Scientific’s Mass Spectrometry Technology Helps Children’s Hospital Boston Isolate Biomarker for Acute Pediatric Appendicitis
publication date: Dec 14, 2009
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that a team of researchers at Children’s Hospital Boston identified a promising biomarker, known as LRG, that they believe will help physicians diagnose acute pediatric appendicitis more accurately and efficiently.
In order to view the full information on press releases, industry news, technical articles, join in on discussions and be able to contact suppliers directly, we ask that you log in/join our community.
If you're not a subscriber why not join today?
If you are already a subscriber, please login. If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to join our community
You will be given immediate access to premium content on the site.
